Evolus (EOLS) Return on Equity (2018 - 2026)

Evolus (EOLS) reported Return on Equity of 0.02% for Q1 2026, down 102.0% on a YoY basis from 0.84% in Q1 2025, and down 15.95% quarter-over-quarter from 0.02% in Q4 2025.

Evolus (EOLS) Return on Equity (2018 - 2026) Analysis & Trends

Evolus has reported Return on Equity for 9 years, with the latest figure at 0.02% in Q1 2026.

  • For the quarter ending Q1 2026, Return on Equity fell 102.0% year-over-year to 0.02%; the trailing twelve-month figure through Mar 2026 stood at 0.02% (down 102.0% YoY), and the FY2025 full-year result was 0.06%, down 1.0% from the prior year.
  • Return on Equity for Q1 2026 stood at 0.02%, down from 0.02% in the prior quarter.
  • The five-year high for Return on Equity was 94.82% in Q2 2023, with the low at 0.09% in Q4 2024.
  • Historically, Return on Equity has averaged 5.66% across 5 years, with a median of 0.02% in 2026.
  • Annual changes were most pronounced in 2023 — Return on Equity surged 9483 bps — and 2024, when it tumbled 9484 bps.
  • Evolus' Return on Equity stood at 0.03% in 2022, then surged by 199 bps to 0.03% in 2023, then sank by 387 bps to 0.09% in 2024, then surged by 123 bps to 0.02% in 2025, then declined by 16 bps to 0.02% in 2026.
  • The last three Return on Equity figures came in at 0.02% (Q1 2026), 0.02% (Q4 2025), and 0.02% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 0.00%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 0.01%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 0.00%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 0.00%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 0.00%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 0.00%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 0.00%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 0.00%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 0.00%
10 Evolus 435.45 Mn 385.65 Mn 48.90 Mn 0.02%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02%
Dec 31, 2025 0.02%
Sep 30, 2025 0.02%
Jun 30, 2025 0.05%
Mar 31, 2025 1.04%
Dec 31, 2024 -0.09%
Sep 30, 2024 -0.04%
Jun 30, 2024 -0.03%
Mar 31, 2024 0.53%
Dec 31, 2023 0.03%
Sep 30, 2023 0.05%
Jun 30, 2023 94.82%
Mar 31, 2023 -0.06%
Dec 31, 2022 -0.03%
Sep 30, 2022 -0.02%
Jun 30, 2022 -0.01%
Mar 31, 2022 -0.01%
Dec 31, 2021 -0.01%
Sep 30, 2021 -0.01%
Jun 30, 2021 -0.02%